Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Humana Inc. (HUM:NYSE), powered by AI.
Humana Inc. is currently trading at $369.49. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Humana Inc. on Alpha Lenz.
Humana Inc.'s P/E ratio is 37.5.
“Humana Inc. trades at a P/E of 37.5 (premium valuation) with modest ROE of 7.0%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.”
Ask for details →Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
“Humana Inc. trades at a P/E of 37.5 (premium valuation) with modest ROE of 7.0%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.”
Ask for details →Humana Inc. (ticker: HUM) is a company listed on NYSE in the Healthcare sector (Healthcare Plans). It has approximately 65,680 employees. Market cap is $44.5B.
The current price is $369.49 with a P/E ratio of 37.46x and P/B of 2.52x.
ROE is 6.98%. Annual revenue is $129.7B.